Multiplex Assay Kit for Lactate Dehydrogenase A (LDHA) ,etc. by FLIA (Flow Luminescence Immunoassay)

LDH-A; LDH-M; LDH1; PIG19; Cell proliferation-inducing gene 19 protein; LDH muscle subunit; Renal carcinoma antigen NY-REN-59

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Lactate Dehydrogenase A (LDHA) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Lactate Dehydrogenase A (LDHA) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Lactate Dehydrogenase A (LDHA) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Lactate Dehydrogenase A (LDHA) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 85-99 93
EDTA plasma(n=5) 98-105 101
heparin plasma(n=5) 95-103 99

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Lactate Dehydrogenase A (LDHA) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Lactate Dehydrogenase A (LDHA) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Lactate Dehydrogenase A (LDHA) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 90-102% 99-105% 87-102% 80-96%
EDTA plasma(n=5) 79-101% 97-105% 88-95% 79-90%
heparin plasma(n=5) 79-98% 95-104% 87-103% 79-92%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:LDHA) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
33 Extracellular Lactate Dehydrogenase A Release From Damaged Neurons Drives Central Nervous System Angiogenesis pubmed:29248508
International Journal of Clinical and Experimental Medicine Effects of fecal microbiota transplantation and joint application of probiotics on rats with alcoholic liver disease
Docosahexaenoic acid (DHA), a nutritional supplement, modulates steroid insensitivity in asthma
Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
ACS Omega SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics 34250342
Nutrients Mokko Lactone Alleviates Doxorubicin-Induced Cardiotoxicity in Rats via Antioxidant, Anti-Inflammatory, and Antiapoptotic Activities. Nutrients 2022, 14, 733 Pubmed:35215383
Pharmaceutics Co-Delivery of Docosahexaenoic Acid and Brain-Derived Neurotropic Factor from Electrospun Aligned Core–Shell Fibrous Membranes in Treatment of Spinal Cord … Pubmed:35214053
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB370Hu01 Recombinant Lactate Dehydrogenase A (LDHA) Positive Control; Immunogen; SDS-PAGE; WB.
PAB370Hu01 Polyclonal Antibody to Lactate Dehydrogenase A (LDHA) WB; IHC; ICC; IP.
LAB370Hu81 FITC-Linked Polyclonal Antibody to Lactate Dehydrogenase A (LDHA) WB; IHC; ICC; IF.
LAB370Hu71 Biotin-Linked Polyclonal Antibody to Lactate Dehydrogenase A (LDHA) WB; IHC; ICC.
MAB370Hu22 Monoclonal Antibody to Lactate Dehydrogenase A (LDHA) WB; IHC; ICC; IP.
SEB370Hu ELISA Kit for Lactate Dehydrogenase A (LDHA) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB370Hu Multiplex Assay Kit for Lactate Dehydrogenase A (LDHA) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.